In Vitro Activity of Methyl Gallate Isolated from Galla Rhois Alone and in Combination with Ciprofloxacin Against Clinical Isolates of Salmonella

被引:39
|
作者
Choi, Jang-Gi [2 ]
Kang, Ok-Hwa [2 ]
Lee, Young-Seob [2 ]
Oh, You-Chang [2 ]
Chae, Hee-Sung [2 ]
Jang, Hye-Jin [2 ]
Kim, Jong Hak [2 ]
Sohn, Dong-Hwan [1 ]
Shin, Dong-Won [3 ]
Park, Hyun [4 ]
Kwon, Dong-Yeul [1 ,2 ]
机构
[1] Wonkwang Univ, Coll Pharm, Dept Pharm, Chonbuk 570749, South Korea
[2] Wonkwang Univ, Wonkwang Oriental Med Res Inst, Chonbuk 570749, South Korea
[3] Sunchon Natl univ, Dept Oriental Med Resources, Sunchon 540742, South Korea
[4] Wonkwang Univ, Coll Med, Dept Parasitol, Chonbuk 570749, South Korea
关键词
Salmonella; ciprofloxacin; methyl gallate; synergism;
D O I
10.4014/jmb.0800.025
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Salmonella remains a primary cause of food poisoning worldwide, and massive outbreaks have been witnessed in recent years. Therefore, this study investigated the antimicrobial activity of methyl gallate (MG), which exhibited good antibacterial activity (MIC=3.9-125 mu g/ml) against all the bacterial strains tested. In a checkerboard dilution test, MG markedly lowered the MICs of ciprofloxacin (CPFX) against Salmonella. The combined activity of CPFX and MG against Salmonella resulted in fractional inhibitory concentrations (FICs) ranging from 0.0037 to 0.015 and from 0.24 to 7.8 mu g/ml, respectively. Meanwhile, the FIC index ranged from 0.31-0.37, indicating a marked synergistic relationship between CPFX and MG against Salmonella. Time-kill assays also showed a decrease in the CFU/ml between the combination and the more active compound. Therefore, this study demonstrated that MG and CPFX can act synergistically in inhibiting Salmonella in vitro.
引用
收藏
页码:1848 / 1852
页数:5
相关论文
共 50 条
  • [41] In Vitro Activity of Trovafloxacin, Ciprofloxacin, Azithromycin, Roxithromycin and Clarithromycin Against 355 Clinical Isolates with Different Resistance Patterns
    José María Casellas
    G. Tomé
    M. Gilardoni
    G. Pagniez
    S. Ivanovic
    Drugs, 1999, 58 : 200 - 202
  • [42] In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood
    Chang, SC
    Chen, YC
    Luh, KT
    Hsieh, WC
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 23 (03) : 105 - 110
  • [43] In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori
    Alarcon, T
    Domingo, D
    Sanchez, I
    deRojas, FD
    LopezBrea, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (12) : 937 - 940
  • [44] Bacterial isolates from the chicken gizzard and ceca with in vitro inhibitory activity against Salmonella typhimurium
    Cosby, DE
    Craven, SE
    Harrison, MA
    Cox, NA
    JOURNAL OF FOOD PROTECTION, 1997, 60 (02) : 120 - 124
  • [45] In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp.
    Pendland, SL
    Killian, AD
    Woodward, JG
    Rodvold, KA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (05) : 651 - 653
  • [46] COMPARATIVE ACTIVITY OF KANAMYCIN, GENTAMICIN AND AMIKACIN ALONE AND IN COMBINATION WITH CEPHALOTHIN OR CHLORAMPHENICOL AGAINST CLINICAL ISOLATES OF KLEBSIELLA SPECIES
    DALESSANDRI, RM
    MCNEELY, DJ
    KLUGE, RM
    CLINICAL RESEARCH, 1975, 23 (05): : A586 - A586
  • [47] COMPARISON OF INVITRO ACTIVITY OF CEFOTAXIME AND DESACETYLCEFOTAXIME ALONE AND IN COMBINATION AGAINST 320 GRAM-NEGATIVE CLINICAL ISOLATES
    PIEDROLA, G
    GALAN, I
    LEYVA, A
    MAROTO, MC
    DRUGS, 1988, 35 : 62 - 64
  • [48] In vitro activity of amixicile against T. vaginalis from clinical isolates
    Eisha Jain
    Edna I. Zaenker
    Paul S. Hoffman
    Cirle A. Warren
    Parasitology Research, 2022, 121 : 2453 - 2455
  • [49] In vitro activity of amixicile against T. vaginalis from clinical isolates
    Jain, Eisha
    Zaenker, Edna, I
    Hoffman, Paul S.
    Warren, Cirle A.
    PARASITOLOGY RESEARCH, 2022, 121 (08) : 2453 - 2455
  • [50] In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe
    Milatovic, D
    Schmitz, FJ
    Verhoef, J
    Fluit, AC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (02) : 293 - U10